Fibrate therapy in the management of dyslipidemias, alone and in combination with statins: role of delayed-release fenofibric acid.

Schima, Susan M

Fibrate therapy in the management of dyslipidemias, alone and in combination with statins: role of delayed-release fenofibric acid. [electronic resource] - Expert opinion on pharmacotherapy Apr 2010 - 731-8 p. digital

Publication Type: Journal Article; Review

1744-7666

10.1517/14656560903575639 doi


Cardiovascular Diseases--etiology
Cholesterol, LDL--blood
Delayed-Action Preparations
Drug Delivery Systems
Dyslipidemias--complications
Fenofibrate--adverse effects
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors--adverse effects
Hypolipidemic Agents--adverse effects